Market revenue in 2023 | USD 89.2 million |
Market revenue in 2030 | USD 329.4 million |
Growth rate | 20.5% (CAGR from 2023 to 2030) |
Largest segment | Pre-clinical |
Fastest growing segment | Pre-clinical |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pre-clinical, Clinical |
Key market players worldwide | Lonza Group Ltd, Catalent Inc, Cytiva, Samsung Electronics Co Ltd, Thermo Fisher Scientific Inc, Novartis AG ADR, Wuxi AppTec Co Ltd, AGC Inc, OmniAb Inc, Rentschler Biopharma SE, Charles River Laboratories International Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy cdmo market will help companies and investors design strategic landscapes.
Pre-clinical was the largest segment with a revenue share of 66.26% in 2023. Horizon Databook has segmented the Middle East & Africa cell and gene therapy cdmo market based on pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as South Africa, Saudi Arabia, the United Arab Emirates (UAE), and Kuwait are prospering economies. The cell & gene therapy CDMO market in the MEA is likely to grow steadily in the forthcoming period.
The increasing burden of diseases and the demand for drugs are some major factors contributing to market growth. In addition, the growing number of clinical trials is anticipated to boost the market over the forecast period.
According to the WHO International Clinical Trials Registry Platform (ICTRP), there were 861 clinical trials registered in Africa in 2022. Moreover, less competition between pharmaceutical companies in underdeveloped countries of the region is attracting various pharmaceutical startups, resulting in regional market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa cell and gene therapy cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa cell and gene therapy cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account